1. HEDSTROM AK, Akerstedt T, Hillert J, Olsson T, et al.
Shift work at young age is associated with increased risk for multiple sclerosis.
Ann Neurol. 2011 Oct 17. doi: 10.1002/ana.22597.
ABSTRACT available
2. BERLANGA-TAYLOR AJ, Disanto G, Ebers GC, Ramagopalan SV, et al.
Vitamin D-gene interactions in multiple sclerosis.
J Neurol Sci. 2011.
ABSTRACT available
3. SEDANI S, Lim M, Hemingway C, Wassmer E, et al.
Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria.
Mult Scler. 2011.
ABSTRACT available
4. FRANCHIGNONI F, Giordano A, Ferriero G.
On dimensionality of the DASH.
Mult Scler. 2011;17:891-2.
5. TEUNISSEN CE, Koel-Simmelink MJ, Pham TV, Knol JC, et al.
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF
mass spectrometry.
Mult Scler. 2011;17:838-50.
ABSTRACT available
6. RITZENTHALER T, Dailler F, Vukusic S, Confavreux C, et al.
First attack of Devic's neuromyelitis optica following endovascular treatment and
rupture of brain arteriovenous malformation.
Mult Scler. 2011;17:895-6.
7. KIRA J.
Astrocytopathy in Balo's disease.
Mult Scler. 2011;17:771-9.
ABSTRACT available
8. VILLAR LM, Espino M, Roldan E, Marin N, et al.
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in
high-risk clinically isolated syndromes.
Mult Scler. 2011;17:690-4.
ABSTRACT available
9. RIISE T, Kirkeleit J, Aarseth JH, Farbu E, et al.
Risk of MS is not associated with exposure to crude oil, but increases with low
level of education.
Mult Scler. 2011;17:780-7.
ABSTRACT available
10. SHINODA K, Matsushita T, Furuta K, Isobe N, et al.
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient
with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody.
Mult Scler. 2011;17:885-7.
ABSTRACT available
11. COLLONGUES N, Marignier R, Zephir H, Blanc F, et al.
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
Mult Scler. 2011;17:720-4.
ABSTRACT available
12. ENZINGER C, Fuchs S, Pichler A, Wallner-Blazek M, et al.
Predicting the severity of relapsing-remitting MS: the contribution of
cross-sectional and short-term follow-up MRI data.
Mult Scler. 2011;17:695-701.
ABSTRACT available
13. GASCA-SALAS C, Gomez-Ibanez A.
[Chronic cerebrospinal venous insufficiency and multiple sclerosis: a review and
update of the subject].
Rev Neurol. 2011;53:555-60.
ABSTRACT available
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an AVONEX(R) prefilled syringe in multiple sclerosis subjects
Phillips J, Fox E, Grainger W, Tuccillo D, Liu S, Deykin A
BMC Neurology 2011, 11:126 (14 October 2011)
[Abstract] [Provisional PDF]
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
Bastianello S, Giugni E, Amato M, Tola M, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F, Study group t
BMC Neurology 2011, 11:125 (14 October 2011)
[Abstract] [Provisional PDF]
Monday, October 24, 2011
MS Articles of Interest
Since I am supplied with these links to papers (abstracts and full papers) from the Cochrane Review people on about a weekly basis, I have asked and received permission from them to post the links here. If you wish to be put on their MS-related mailing list, let me know and I'll send your name to them. Remember, Cochrane Reviews is not endorsing any of these research articles, rather simply letting us know about them:
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment